//
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment